Use of Domperidone to increase breast milk supply: Are women really dying to breastfeed?

Research output: Contribution to journalLetter

8 Citations (Scopus)

Abstract

As outrageous as it may seem, recent reports would have you believe that women are indeed risking their lives to breastfeed their infants. The potential for domperidone to prolong the QT interval and increase the risk of fatal cardiac arrhythmias among susceptible users has been known for a number of years.1 Of particular interest is the concept of susceptibility, as original case reports of fatal cardiac arrhythmias involved the administration of high dose intravenous domperidone to cancer patients. This led to warnings by the US Food and Drug Administration and its subsequent complete withdrawal from the US market, in addition to the withdrawal of the intravenous formulation from other markets. The oral form of domperidone, however, has remained available for use in many other countries.
Original languageEnglish
Pages (from-to)498-499
Number of pages2
JournalJournal of Human Lactation
Volume30
Issue number4
DOIs
Publication statusPublished - Nov 2014
Externally publishedYes

Keywords

  • Domperidone
  • Breast Milk Supply
  • Increased Breast Milk Supply
  • Prolonged QT interval
  • fatal cardiac arrhythmia
  • intravenous domperidone
  • oral form of domperidone
  • sudden cardiac death
  • SCD

Fingerprint Dive into the research topics of 'Use of Domperidone to increase breast milk supply: Are women really dying to breastfeed?'. Together they form a unique fingerprint.

Cite this